Primary Outcome Measures:
- HF-specific quality of life [ Time Frame: baseline, midpoint, endpoint, 6mo ] [ Designated as safety issue: No ]
- functional capacity [ Time Frame: baseline and endpoint ] [ Designated as safety issue: No ]
- Walking Test [ Time Frame: baseline, midpoint, endpoint ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- General quality of life [ Time Frame: baseline, midpoint, endpoint, 6mo ] [ Designated as safety issue: No ]
- mood and emotional status [ Time Frame: baseline, midpoint, endpoint, 6mo ] [ Designated as safety issue: No ]
- exercise self-efficacy [ Time Frame: baseline, midpoint, endpoint, 6mo ] [ Designated as safety issue: No ]
- sense of coherence [ Time Frame: baseline, midpoint, endpoint, 6mo ] [ Designated as safety issue: No ]
- utility assessment [ Time Frame: baseline, midpoint, endpoint, 6mo ] [ Designated as safety issue: No ]
- beliefs, attitudes, and expectations [ Time Frame: baseline, midpoint, endpoint ] [ Designated as safety issue: No ]
- physical activity level [ Time Frame: baseline, midpoint, endpoint ] [ Designated as safety issue: No ]
- perceived social support [ Time Frame: baseline, midpoint, endpoint ] [ Designated as safety issue: No ]
- neurohormonal status [ Time Frame: baseline, midpoint, endpoint ] [ Designated as safety issue: No ]
- autonomic tone, heart rate variability [ Time Frame: baseline and endpoint ] [ Designated as safety issue: No ]
- echocardiography [ Time Frame: baseline and endpoint ] [ Designated as safety issue: No ]
- costs and use of HF services [ Time Frame: baseline and endpoint ] [ Designated as safety issue: No ]
HF is a major public health problem in the United States, affecting approximately 5 million adults. Despite recent advances in pharmacologic therapy and technologic devices, HF is the most common reason for hospitalization among Medicare patients and is reaching epidemic proportions as the population ages. New and inexpensive interventions that can improve functional capacity and quality of life and can delay disease progression are needed. Tai chi is a popular mind-body exercise that is a potential treatment for heart disease. This exercise incorporates both gentle physical activity and meditation, and it may be particularly suited to frail patients with HF. This study will examine the effects of a tailored tai chi program on functional capacity and quality of life in patients with HF.
Participants will be randomly assigned to either a tai chi program or heart health education for 12 weeks. Participants in both groups will undergo a bicycle stress test at study entry and will receive weekly training sessions of their assigned intervention. Self-report scales and questionnaires will be used to assess participants at study start and at the end of 12 weeks.